Nicolas Thomas

MTU Targets Drone Propulsion With a Focused Acquisition

April 08, 2026 at 09:30 am EDT

Governance crisis at Indra: Chairman resigns

Indra's Chairman is stepping down following a conflict of interest linked to a controversial transaction. The episode underscores internal tensions and the growing influence of the Spanish state.

April 02, 2026 at 01:29 am EDT

Governance crisis at Indra: chairman resigns

Indra's chairman is stepping down after a conflict of interest tied to a controversial deal. The episode highlights internal tensions and the growing influence of the Spanish state.

April 01, 2026 at 01:56 pm EDT

Novo Nordisk cuts Wegovy prices to win over uninsured patients

The Danish drugmaker is stepping up its US commercial strategy as competition from Eli Lilly intensifies. It is betting on subscription offers and telemedicine partnerships to broaden access to its treatment.

March 31, 2026 at 10:14 am EDT

Volvo Becomes Lynk & Co's Exclusive Distributor in Europe

Volvo is stepping up synergies within the Geely group by taking over distribution of the Lynk & Co brand in Europe. The move is intended to speed up commercial development without additional investment.

March 30, 2026 at 12:51 pm EDT

Paris and Berlin attempt to relaunch European FCAS fighter jet program

France and Germany are seeking to overcome tensions surrounding the Future Combat Air System program, weakened by industrial disagreements between Dassault Aviation and Airbus.

March 17, 2026 at 02:20 pm EDT

Kone in talks to acquire TK Elevator for up to EUR25bn

March 16, 2026 at 05:05 pm EDT

Kone in talks to buy TK Elevator for up to €25bn

March 16, 2026 at 03:03 pm EDT

Webuild shares slide following disappointing 2026 outlook

Italian construction group Webuild reported better 2025 results, although its outlook for 2026 disappointed investors, causing its shares to tumble, down nearly 9% by noon. Operating profit (EBITDA) rose 18% to EUR1.16bn. Annual adjusted net profit increased by 13% to EUR280m, while revenue grew by 15% to EUR13.6bn.

March 12, 2026 at 09:50 am EDT

Webuild shares fall after 2026 outlook seen as disappointing

Italian construction group Webuild reported higher results for 2025, but its 2026 outlook disappointed investors, sending the stock down nearly 9% by mid-session. Operating profit (EBITDA) rose 18% to €1.16bn. Annual adjusted net profit increased 13% to €280m, while revenue climbed 15% to €13.6bn.

March 12, 2026 at 09:31 am EDT

Rio Tinto secures $1.18bn in financing for its lithium project in Argentina

The Anglo-Australian mining group strengthens funding for the Rincon mine, set to produce battery-grade lithium.

March 10, 2026 at 02:40 pm EDT

Glencore Weighs an Australian Listing After Merger Talks With Rio Tinto Collapse

March 09, 2026 at 11:53 am EDT

BP Seeks at Least $3.7bn From Venture Global After LNG Arbitration

March 06, 2026 at 11:53 am EST

Bank of England creates an executive director role for monetary policy

February 24, 2026 at 12:18 pm EST

Pernod Ricard Considers IPO for Its Indian Subsidiary

February 18, 2026 at 02:02 pm EST

Investigation in France into Contaminated Infant Formula: Nestlé, Danone, and Lactalis Under Scrutiny

February 16, 2026 at 02:27 pm EST

AXA: RBC Starts Coverage at "Outperform" with a Price Target of €48

RBC Europe Limited initiates coverage of AXA with an "Outperform" recommendation and a price target of €48, compared to the current price of €37.46.

February 16, 2026 at 01:42 pm EST

ETFs: how to tap the potential of 24 emerging markets?

Investing in emerging markets came back into fashion last year. After several years lagging developed markets, large caps in emerging countries benefited from renewed interest, partly linked to doubts over the consequences of the upheavals underway in the US. To track this momentum, MSCI offers a benchmark barometer: the MSCI Emerging Markets Index (USD), from which many ETFs are derived.

February 13, 2026 at 06:09 am EST

BP Sells a Stake in Its Shafag Solar Project to MVM

February 11, 2026 at 10:18 am EST

Novo Nordisk exposed to a price war over obesity treatments

(MarketScreener with Reuters) Novo Nordisk's new chief executive could find himself on the wrong side of a potentially destructive price war, as what analysts and investors describe as "unprecedented" pricing pressure forces the Danish group to cut the US price of its flagship obesity drug, Wegovy.

February 04, 2026 at 02:38 pm EST

ETFs: how to bet on European value?

At a time when doubts are starting to build around the technology sector and volatility is making investors uneasy, there is a big temptation to explore calmer territory. It is an opportunity to dust off the classic battle between growth stocks and discounted value stocks.

February 04, 2026 at 10:08 am EST